CytomX Therapeutics (NASDAQ:CTMX) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:15 PM.
Here's what investors need to know about the announcement.
Earnings
CytomX Therapeutics missed estimated earnings by 42.86%, reporting an EPS of $-0.4 versus an estimate of $-0.28.
Revenue was up $3.35 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04 which was followed by a 10.37% increase in the share price the next day.
Here's a look at CytomX Therapeutics's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.31 | -0.32 | -0.35 | -0.50 |
| EPS Actual | -0.35 | -0.30 | -0.26 | -0.31 |
| Revenue Estimate | 18.08M | 16.86M | 15.43M | 15.41M |
| Revenue Actual | 17.59M | 16.29M | 15.97M | 16.37M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
